Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bartsevich, V. V.
Right arrow Articles by Pabo, C. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bartsevich, V. V.
Right arrow Articles by Pabo, C. O.

Stem Cells 2003;21:632-637 www.StemCells.com
© 2003 AlphaMed Press


Rapid Communication

Engineered Zinc Finger Proteins for Controlling Stem Cell Fate

Victor V. Bartsevich, Jeffrey C. Miller, Casey C. Case, Carl O. Pabo

Sangamo BioSciences, Inc., Point Richmond Tech Center, Richmond, California, USA

Key Words. Zinc finger proteins • Embryonic stem cells • Differentiation

Correspondence: Victor V. Bartsevich, Ph.D., Sangamo BioSciences, Inc., Point Richmond Tech Center, 501 Canal Boulevard, Suite A100, Richmond, California 94804, USA. Telephone: 510-970-6000, ext. 253; Fax: 510-236-8951; e-mail: victorb{at}sangamo.com

Stem cells are functionally defined as progenitor cells that can self-renew and differentiate. Critical transitions in these cells are controlled via signaling pathways and subsequent transcriptional regulation. Technologies capable of modulating the levels of gene expression, especially those of transcription factors, represent powerful tools for research and could potentially be used in therapeutic applications. In this study, we evaluated the ability of synthetic zinc finger protein transcription factors (ZFP-TFs) to cause the differentiation of embryonic stem (ES) cells. We constructed ZFP-TFs that target the mouse Oct-4 gene (which is a major regulator of ES cell pluripotency and self-renewal). These designed transcription factors were able to regulate the transcription of Oct-4, affecting the expression of downstream genes and thus regulating ES cell differentiation.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Santiago, E. Chan, P.-Q. Liu, S. Orlando, L. Zhang, F. D. Urnov, M. C. Holmes, D. Guschin, A. Waite, J. C. Miller, et al.
From the Cover: Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases
PNAS, April 15, 2008; 105(15): 5809 - 5814.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
S L Rodriguez-Zas, Y Ko, H A Adams, and B R Southey
Advancing the understanding of the embryo transcriptome co-regulation using meta-, functional, and gene network analysis tools
Reproduction, February 1, 2008; 135(2): 213 - 224.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. Durai, M. Mani, K. Kandavelou, J. Wu, M. H. Porteus, and S. Chandrasegaran
Zinc finger nucleases: custom-designed molecular scissors for genome engineering of plant and mammalian cells
Nucleic Acids Res., October 26, 2005; 33(18): 5978 - 5990.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
H.-S. Kwon, H.-C. Shin, and J.-S. Kim
Suppression of vascular endothelial growth factor expression at the transcriptional and post-transcriptional levels
Nucleic Acids Res., April 28, 2005; 33(8): e74 - e74.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. Blancafort, D. J. Segal, and C. F. Barbas III
Designing Transcription Factor Architectures for Drug Discovery
Mol. Pharmacol., December 1, 2004; 66(6): 1361 - 1371.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2003 by AlphaMed Press.